What happens during the disease - острый миелофиброз
The pathogenesis of acute myelofibrosis is thought to involve a combination of genetic and environmental factors, including mutations in the jak2 gene, as well as exposure to certain toxins or chemicals. these mutations lead to an increased production of abnormal proteins, which can cause the bone marrow to become fibrotic and unable to produce healthy blood cells. this leads to anemia, fatigue, and other symptoms associated with acute myelofibrosis.
Treatment and Medical Assistance
Main goal: To reduce the symptoms and prevent further damage to the body.
- Prescribing medications to reduce inflammation and pain
- Physical therapy to improve muscle strength and flexibility
- Occupational therapy to help adapt to daily activities
- Corticosteroid injections to reduce inflammation
- Surgery to remove affected areas of tissue
- Plasma exchange to remove harmful antibodies
- Stem cell transplantation to replace damaged cells
- Nutritional counseling to ensure proper nutrition
- Regular follow-up appointments to monitor the disease
![Icon](/img/svg/Medic/days_in_hospital.svg)
14 Days of Hospitalization Required
![Icon](/img/svg/Medic/days_in_ambulance.svg)
Average Time for Outpatient Care Not Established